A significant shift in Canadian drug policy has happened, as the authorities announce the legalization of psilocybin hallucinogens for therapeutic treatment. Previously, these substances were severely restricted, but a mounting body of studies suggests they potentially offer aid for psychological illnesses like depression. This change represents a